Page 130 - Biomedical Engineering and Design Handbook Volume 2, Applications

OVERVIEW OF CARDIOVASCULAR DEVICES 109

Triolo, P. M. and J. D. Andrade (1983b). “Surface modification and evaluation of some commonly used catheter
materials. I. Surface properties.” J Biomed Mater Res, 17(1):129–47.
Tumlin, J., R. Wali, et al. (2008). “Efficacy and safety of renal tubule cell therapy for acute renal failure.” J Am
Soc Nephrol, 19(5):1034–40.
Turco, M. A., M. Buchbinder, et al. (2006). “Pivotal, randomized U.S. study of the Symbiottrade mark covered
stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from
the Symbiot III trial.” Catheter Cardiovasc Interv, 68(3):379–88.
Twardowski, Z. J. (1998). “High-dose intradialytic urokinase to restore the patency of permanent central vein
hemodialysis catheters.” Am J Kidney Dis, 31(5):841–7.
Tyers, G. F., P. Mills, et al. (1997). “Bipolar leads for use with permanently implantable cardiac pacing systems:
a review of limitations of traditional and coaxial configurations and the development and testing of new con-
ductor, insulation, and, electrode designs.” J Invest Surg, 10(1–2):1–15.
US Renal Data System (2000). USRDS 2000 Annual Data Report: National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of Health, Bethesda, MD, U.S.A.
US Renal Data System (2007). USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-
Stage Renal Disease in the United States. National Institute of Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, Bethesda, MD, U.S.A.
Valles, J., C. Leon, et al. (1997). “Nosocomial bacteremia in critically ill patients: a multicenter study evaluating
epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad
Espanola de Medicina Intensive y Unidades Coronarias (SEMIUC).” Clin Infect Dis, 24(3):387–95.
Van Belle, E., S. Susen, et al. (2007). “Drug-eluting stents: trading restenosis for thrombosis?” J Thromb
Haemost, 5 (Suppl 1):238–45.
Vaucher, Y. E., G. G. Dudell, et al. (1996). “Predictors of early childhood outcome in candidates for extracorporeal
membrane oxygenation.” J Pediatr, 128(1):109–17.
Veith, F. J., S. K. Gupta, et al. (1986). “Six-year prospective multicenter randomized comparison of autologous
saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions.” J Vasc
Surg, 3(1):104–14.
Verin, V., Y. Popowski, et al. (2001). “Endoluminal beta-radiation therapy for the prevention of coronary resteno-
sis after balloon angioplasty. The Dose-Finding Study Group.” N Engl J Med, 344(4):243–9.
Virmani, R. and A. Farb (1999). “Pathology of in-stent restenosis.” Curr Opin Lipidol, 10(6):499–506.
Vongpatanasin, W., L. D. Hillis, et al. (1996). “Prosthetic heart valves.” N Engl J Med, 335(6):407–16.
Wagner, W. R., P. C. Johnson, et al. (1993). “Evaluation of bioprosthetic valve-associated thrombus in ventricular
assist device patients.” Circulation, 88(5 Pt l):2023–9.
Waksman, R. (1999). “Intracoronary radiation therapy for restenosis prevention: status of the clinical trials.”
Cardiovasc Radiat Med, 1(1):20–9.
Watanabe, H., J. Hayashi, et al. (1999). “Biocompatibility of a silicone-coated polypropylene hollow fiber
oxygenator in an in vitro model.” Ann Thorac Surg, 67(5):1315–9.
Weeks, S. M. (2002). “Unconventional venous access.” Tech Vasc Interv Radiol, 5(2):1l4–20.
Wegner, J. A. (1997). “Oxygenator anatomy and function.” J Cardiothorac Vasc Anesth, 11(3):275–81.
Wendel, H. P. and G. Ziemer (1999). “Coating-techniques to improve the hemocompatibility of artificial devices
used for extracorporeal circulation.” Eur J Cardiothorac Surg, 16(3):342–50.
Wesolowski, S. A., C. C. Fries, et al. (1961). “Porosity: primary determinant of ultimate fate of synthetic vascular
grafts.” Surgery, 50:91–6.
Williams, S. K., T. Carter, et al. (1992). “Formation of a multilayer cellular lining on a polyurethane vascular graft
following endothelial cell sodding.” J Biomed Mater Res, 26(1):103–17.
Willman, V. L., J. M. Anderson, et al. (1999). Expert panel review of the NHLBI Total Artificial Heart (TAH)
Program June 1998–November 1999. National Heart Lung and Blood Institute, National Institutes of Health,
Bethesda, MD, USA: 28pp.
Wilson, W., K. A. Taubert, et al. (2007). “Prevention of infective endocarditis: guidelines from the American
Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and
Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical
Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes
Research Interdisciplinary Working Group.” Circulation, 116(15):1736–54.